Your Mouth's Microbiome Can Be Reprogrammed to Fight Disease
A comprehensive review reveals how probiotics, bacteriophages, and predatory bacteria can restore oral microbial balance and prevent systemic disease.
Gut microbiome, probiotics, gut-brain axis, and digestive health
290 articles
A comprehensive review reveals how probiotics, bacteriophages, and predatory bacteria can restore oral microbial balance and prevent systemic disease.
A systematic review of 99 studies reveals how AI is transforming biomaterial design to combat drug-resistant oral infections.
A nationwide Korean birth cohort study finds maternal influenza infection in pregnancy may raise offspring risk of inflammatory bowel disease.
First Mendelian randomization study finds 17 bacterial taxa causally influence white matter integrity, connectivity, and stroke risk.
A 51-calf field trial reveals how the feed additive 3-NOP slashes methane by 62% but causes hydrogen buildup that limits productivity gains.
A new review maps the bidirectional crosstalk between gut microbiota and cellular senescence driving multi-organ degeneration.
A toxin-producing gut bacterium rewires colon cell metabolism, creating an oxygen-rich niche that fuels its own growth — with implications for colitis and colorectal cancer.
Allez au-delà des probiotiques et des fibres — explorez la science de pointe de la transplantation de microbiote fécal, des postbiotiques élaborés par ingénierie, et découvrez comment l'intestin orchestre le vieillissement systémique à travers les circuits immunitaires et neuronaux.
Faites connaissance avec les billions de microbes qui vivent en vous — et découvrez pourquoi la santé de votre communauté intestinale est peut-être l'un des facteurs les plus déterminants pour la durée et la qualité de votre vie.
TaxVAMB uses deep learning to dramatically improve how scientists reconstruct individual microbial genomes from complex gut microbiome samples.
Commensal yeast in the gut microbiome may actively boost Salmonella Typhimurium virulence, reshaping how we think about infection risk.
Synthetic biology meets the microbiome: designer probiotics restore gut-liver-brain balance better than rifaximin in preclinical models.